Cargando…
Co-transplantation of Human Fetal Mesenchymal and Hematopoietic Stem Cells in Type 1 Diabetic Mice Model
Introduction: Cell therapy can overcome the limitation of conventional treatments (including different medications and β cell replacement) for type 1 diabetes. Based- on several studies human fetal mesenchymal and hematopoietic stem cells are ideal candidates for stem cell therapy. On the other hand...
Autores principales: | Arjmand, Babak, Goodarzi, Parisa, Aghayan, Hamid Reza, Payab, Moloud, Rahim, Fakher, Alavi-Moghadam, Sepideh, Mohamadi-jahani, Fereshteh, Larijani, Bagher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856665/ https://www.ncbi.nlm.nih.gov/pubmed/31781036 http://dx.doi.org/10.3389/fendo.2019.00761 |
Ejemplares similares
-
Auxiliary role of mesenchymal stem cells as regenerative medicine soldiers to attenuate inflammatory processes of severe acute respiratory infections caused by COVID-19
por: Parhizkar Roudsari, Peyvand, et al.
Publicado: (2020) -
Mesenchymal stem cell as a novel approach to systemic sclerosis; current status and future perspectives
por: Abedi, Mina, et al.
Publicado: (2020) -
Prospect of Stem Cell Therapy and Regenerative Medicine in Osteoporosis
por: Arjmand, Babak, et al.
Publicado: (2020) -
Zebrafish for Personalized Regenerative Medicine; A More Predictive Humanized Model of Endocrine Disease
por: Arjmand, Babak, et al.
Publicado: (2020) -
Metabolomics Analysis of Mesenchymal Stem Cells
por: Goodarzi, Parisa, et al.
Publicado: (2019)